Farah Nabil, and Mohammed Saleem. 2026. “First-Line FOLFIRINOX Vs Gemcitabine ± Nab-Paclitaxel in Metastatic Pancreatic Adenocarcinoma: Real-World Treatment Response and Clinicopathologic Predictors from a 2022 Tertiary-Center Cohort”. Middle Eastern Cancer and Oncology Journal 2 (2): 11-17. https://doi.org/10.61706/MECOJ160191.